Results In Line, But Weak Organic Growth
China TCM's 2015 results met expectations (operating profit +56%/EPS +3%), but the shares have declined by roughly 11% in response to very tepid...
310 Views
Just What the Doctor Ordered
This is a quick update on Kemp Dolliver's previous insight "Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling...
413 Views
Positive Profit Warning Suggests In-Line Results
China TCM has issued a positive profit warning (attached) for the year ended 31 December 2015: Increase in net income of "not less than 50%" over...
330 Views
Coming to the HKEX Soon....................
Bloomberg has published a story (that others have cited) that WuXi Pharmatech has picked bankers for an HK listing of its biologics manufacturing...
343 Views
Time to Go Shopping for Healthcare
The decline in equity markets has created opportunities to buy a variety of healthcare stocks at attractive valuations. Insider purchases have...
360 Views